Using the Arms to Drive the Legs During Walking
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03689647|
Recruitment Status : Unknown
Verified September 2018 by Christopher Arellano, University of Houston.
Recruitment status was: Not yet recruiting
First Posted : September 28, 2018
Last Update Posted : October 2, 2018
|Condition or disease||Intervention/treatment||Phase|
|Metabolic Cost of Walking With Arm Swing Assistive Device||Device: Arm Swing Driven Assistive Apparatus||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||Reducing Metabolic Cost of Walking by Exploiting Arm Swing to Drive Leg Swing|
|Estimated Study Start Date :||October 1, 2018|
|Estimated Primary Completion Date :||December 31, 2018|
|Estimated Study Completion Date :||December 31, 2018|
Experimental: Single Group Experimental
Each participant will act as their own control with variables of interest measured while walking without the assistive device and while walking with the assistive device.
Device: Arm Swing Driven Assistive Apparatus
The investigators are testing a simple, custom built apparatus to determine if it can facilitate the use of the arms to swing the legs during walking. More specifically, the investigators will measure how this assistive apparatus affects the metabolic cost and biomechanics of walking.
- Metabolic Cost [ Time Frame: Change from walking without assistive apparatus to walking with assistive apparatus. Measures of metabolic cost are completed within a 3-hour time window during a single laboratory visit. ]Change in Metabolic Cost
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03689647
|Contact: Christopher J Arellano, PhDemail@example.com|
|Principal Investigator:||Christopher J Arellano, PhD||University of Houston|